切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2015, Vol. 09 ›› Issue (05) : 326 -329. doi: 10.3877/cma. j. issn.1674-0807.2015.05.009

综述

有丝分裂激酶Aurora-A 介导乳腺癌发生与耐药的研究进展
谢杰锋1,2, 姚昶3, 张亚男1,2,()   
  1. 1.210009 南京,东南大学医学院
    2.210009 南京,附属中大医院普外科
    3.210029 南京,江苏省中医院乳腺外科
  • 收稿日期:2015-03-12 出版日期:2015-10-01
  • 通信作者: 张亚男

Aurora-A mediated development and drug resistance of breast cancer

Jiefeng Xie, Chang Yao, Yanan Zhang()   

  • Received:2015-03-12 Published:2015-10-01
  • Corresponding author: Yanan Zhang
引用本文:

谢杰锋, 姚昶, 张亚男. 有丝分裂激酶Aurora-A 介导乳腺癌发生与耐药的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2015, 09(05): 326-329.

Jiefeng Xie, Chang Yao, Yanan Zhang. Aurora-A mediated development and drug resistance of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2015, 09(05): 326-329.

[1]
Tanner MM, Tirkkonen M, Kallioniemi A, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes[J]. Cancer Res,1994,54(16):4257-4260.
[2]
Nikonova AS, Astsaturov I, Serebriiskii IG, et al. Aurora A kinase (AURKA) in normal and pathological cell division[J].Cell Mol Life Sci,2013,70(4):661-687.
[3]
Wang Y, Wang Z, Qi Z, et al. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression,cytokinesis, and tetraploidy[J]. Mol Cancer,2014,13:94.
[4]
Pérez de Castro I, Aguirre-Portolés C, Fernández-Miranda G,et al. Requirements for Aurora-A in tissue regeneration and tumor development in adult mammals[J]. Cancer Res,2013,73(22):6804-6815.
[5]
Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines[J]. Oncogene,1997,14(18):2195-2200.
[6]
Miyoshi Y,Iwao K,Egawa C,et al. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers[J]. Int J Cancer,2001,92(3):370-373.
[7]
Rouquier S, Pillaire MJ, Cazaux C, et al. Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers[J]. Dis Markers,2014,2014:798 170.
[8]
Wang X, Zhou YX, Qiao W, et al. Overexpression of Aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation[J]. Oncogene,2006,25(54):7148-7158.
[9]
Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells[J]. EMBO J,2002,21(4):483-492.
[10]
Zhang H, Chen X, Jin Y, et al. Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability [ J ]. Eur Arch Otorhinolaryngol,2012,269(2):607-614.
[11]
Roylance R, Endesfelder D, Jamal-Hanjani M, et al.Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer[J]. Breast Cancer Res Treat,2014,148(1):221-229.
[12]
Oda-Sato E,Tanaka N. Abnormal centrosome amplification and Aurora-A activation in p53-deficient cells[J]. J Nippon Med Sch,2007,74(6):384-385.
[13]
Katayama H, Sasai K, Kawai H, et al. Phosphorylation by Aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53[J]. Nat Genet,2004,36(1):55-62.
[14]
Zorba A, Buosi V, Kutter S, et al. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2[J]. Elife,2014,3:e02667.
[15]
Furukawa T, Kanai N, Shiwaku HO, et al. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer[J]. Oncogene,2006,25(35):4831-4839.
[16]
Sankaran S, Crone DE, Palazzo RE, et al. Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation[J]. Cancer Res,2007,67(23):11 186-11 194.
[17]
Xu LZ, Long ZJ, Peng F, et al. Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells[J]. Oncotarget,2014,5(17):7498-7511.
[18]
Opyrchal M, Salisbury JL, Zhang S, et al. Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells[J]. PLoS One,2014,9(5):e96995.
[19]
Zheng XQ, Guo JP, Yang H, et al. Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer[J]. Oncogene,2014,33(42):4985-4996.
[20]
Sun H, Wang Y, Wang Z,et al. Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks[J]. Biochim Biophys Acta,2014,1843(5):934-944.
[21]
Katayama H, Wang J, Treekitkarnmongkol W, et al. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73[J].Cancer Cell,2012,21(2):196-211.
[22]
Long M, Yin G, Liu L, et al. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells[J]. Cancer Gene Ther,2012,19(4):271-281.
[23]
Li JP, Yang YX, Liu QL, et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells[J].Drug Des Devel Ther,2015,9:1627-1652.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要